Research2 sources
Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy
Nature · By Jana Zarubova ·
The Brief · written from 2 sources
- Two papers published online in Nature Nanotechnology on 18 November 2026 report that pluripotent stem cells secrete extracellular vesicles with unique molecular signatures and immunomodulatory activity.
- The second paper reports that these vesicles induce immune tolerance and can be produced at scale in suspension culture.
- The second paper also reports delivery from an injectable hydrogel in the context of diabetes therapy; the source excerpt is cut off before stating the protective outcome.
Why it matters
The work suggests a cell-free approach to immune tolerance that could be relevant to diabetes therapy, and its scalable production and injectable delivery are the practical points for researchers to evaluate.
Who’s affected
- immunology and diabetes researchers
- nanomedicine and stem cell researchers
- #extracellular vesicles
- #immune tolerance
- #diabetes
- #stem cells
- #nanomedicine
Nature Nanotechnology, Published online: 18 November 2026; doi:10.1038/s41565-026-02320-z Pluripotent stem cells secrete extracellular vesicles that induce immune tolerance and, when produced at scale in suspension culture and delivered from an injectable hydrogel, protect…
Timeline
Full coverage · 2 sources
- 19h ago ↗
nature.com
A pluripotent source of immune tolerance - 19h ago ↗
nature.com
Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy